Lymphoma: What Chemotherapy Can and Can't Do
Most dogs with lymphoma go into remission on chemotherapy, but few are cured. What the published remission and survival figures show, and what they can't.
Written by thecanineledger
This page carries no advertising, and nothing on it is for sale.
If your dog is having trouble breathing, collapses, or, during chemotherapy, stops eating, keeps vomiting or seems very flat: call your vet or the oncology team now. Don’t wait for the next appointment.
Our note: The warning signs during chemotherapy are ours. None of our sources gives owners a list.
A 2023 review of nearly five decades of studies on dogs with lymphoma reached a sobering verdict. While individual papers have reported much better survival, “over the last 40 years, the overall improvement in outcome has been modest at best” (Bennett et al., Veterinary Sciences 2023).
While that sounds bleak, it isn’t the whole story. Most dogs treated with multi-drug chemotherapy go into remission, and many have months of good-quality life. This page explains what remission means, what the published figures show, and why they vary so much.
1. What lymphoma is
Lymphoma is a cancer of lymphocytes, a type of white blood cell. The Merck Veterinary Manual calls it “a progressive, deadly disease caused by the harmful growth of lymphocytes” (Merck Veterinary Manual, owner version).
The commonest form. Multicentric lymphoma, which affects many lymph nodes, accounts for “about 80%-85% of cases.” Merck says an early sign is “the rapid and nonpainful enlargement of lymph nodes”. Later, dogs may become weak, feverish and lose their appetite.
Diagnosis. Merck says “a needle biopsy of enlarged lymph nodes usually provides enough cells to confirm the diagnosis.”
B-cell or T-cell. Most lymphomas involve either B cells or T cells. The type matters for the outlook (section 2).
→ Found a Lump? Why Your Vet Should Put a Needle in It
2. Remission is not cure
Remission means the cancer has shrunk. In a complete remission, the vet can no longer find it. In a partial remission, it has shrunk but not gone.
Most dogs respond. For high-grade multicentric lymphoma, Merck says multi-drug chemotherapy “is often successful, with more than 90% of all dogs achieving complete remission”.
Most dogs relapse. Remission usually lasts months, not years. Merck gives an expected survival with chemotherapy of “about 12 months” for B-cell lymphoma. “For dogs with T-cell lymphoma, expected survival times are shorter (6 months).”
Low-grade lymphoma is different. Merck says dogs with low-grade lymphoma “tend to do well and with chemotherapy can survive longer than two years.”
Our note: Merck’s 90% complete remission is higher than the 77% median in the 2023 review. We give both.
3. What the studies actually report
The 2023 review pulled together studies from 1973 to 2021. For multicentric or nodal lymphoma treated with the standard multi-drug protocol, it found 43 papers covering 4,382 dogs. Across those studies:
| Measure | Range across studies | Median of the studies |
|---|---|---|
| Complete remission | 25–100% | 77% |
| Median remission time | 41–414 days | 196 days |
| Median survival time | 73–622 days | 267 days |
| Alive at 1 year | 28–70% | — |
| Alive at 2 years | 6–33% | — |
Why the range is so wide. The authors found a “lack of standardised approaches to evaluate and report the outcomes”. Studies defined remission differently and started the clock at different points. Some included only dogs that responded.
Owners’ choices change the figures. The review notes that survival “is affected by other factors such as the owners’ willingness to pursue repeated chemotherapy, for financial or logistical reasons, and the availability of euthanasia”.
4. What predicts how a dog will do
You may read that certain test results decide the outlook. The 2023 review found the evidence for most of them is weaker than commonly said.
Two factors held up best. Only “immunophenotype and response to treatment were prognostic in greater than 50% of the papers evaluated”. Immunophenotype means B-cell or T-cell.
Others were less consistent. High blood calcium and “substage” (whether the dog is unwell at diagnosis) are often cited, but the review found each was prognostic in under 40% of the papers that looked at it.
What it means for you. Your vet’s estimate for your dog is a best guess from imperfect studies. Ask what it’s based on.
5. Living with chemotherapy
Side effects. A 2026 UK study asked owners to record their dog’s signs every day for three weeks of chemotherapy. Of 27 dogs, 22 had tiredness at some point, 12 had a poor appetite, 11 had diarrhoea and 10 vomited (Harris et al., Veterinary and Comparative Oncology 2026). The study included dogs with several cancers, not only lymphoma, and the authors note the signs “may reflect chemotherapy side effects, cancer‐related side effects, concurrent medications that are not cytotoxic, or be from unrelated conditions.”
Quality of life. In that study, “QoL scores over time remained relatively stable for most dogs”. It was small, and owner-reported.
Treatment is shorter than it was. Merck says “similar or improved responses are seen with shorter term therapies, and chemotherapy is often stopped once remission is reached.”
Our note: We don’t cover steroid-only treatment or treatment after relapse. Ask your vet about options if full chemotherapy isn’t possible.
→ Living With a Diagnosis: What Your Vet Told You, and What to Ask Next · → Reading Pain in an Old or Sick Dog
6. If you decide against chemotherapy
Choosing not to treat, or stopping, is a reasonable decision. Lymphoma is not usually curable, and the aim of treatment is good-quality time. Talk to your vet about comfort care, and about how you’ll know when it’s time.
→ Hospice & Palliative Care for Dogs · → How to Know When It’s Time to Say Goodbye
7. What we could not verify
| Commonly said | What we found |
|---|---|
| “Chemo cures lymphoma in dogs” | Rarely. Most dogs go into remission, but most relapse. |
| “Dogs suffer terribly on chemo” | Not usually. In one small study, quality of life stayed stable for most dogs, though tiredness and poor appetite were common. |
| “Survival is 12 months” | Sometimes. That’s Merck’s figure for B-cell lymphoma. Study medians range from 73 to 622 days. |
| “High calcium means a poor outlook” | Not consistently. It was prognostic in under 40% of studies that looked at it. |
| “Treatment has improved a lot” | Modestly. The 2023 review found little overall improvement over 40 years. |
Sources
- Bennett P, Williamson P, Taylor R. Review of Canine Lymphoma Treated with Chemotherapy: Outcomes and Prognostic Factors. Vet Sci 2023: thematic review, 1973–2021. No external funding
- Fan TM. Malignant Lymphoma in Dogs. Merck Veterinary Manual, owner version, last updated September 2024. ⚠️ not peer-reviewed. Expert reference
- Harris J, Sutton K, Fournier Q, et al. Development and Testing of an Owner-Reported Outcome Measure of Clinical Signs and Quality of Life in Dogs Treated With Chemotherapy. Vet Comp Oncol 2026: pilot study, 29 owners, mixed cancers. Funded by the Kennel Club Charitable Trust
Always confirm with your vet before acting on anything on this page.